ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway
Abstract Background Drug resistance is one of the major concerns in the treatment of hepatocellular carcinoma (HCC). The aim of the present study was to determine whether aberrant high expression of the inhibitor of differentiation 1(ID1) confers oxaliplatin-resistance to HCC by activating the pento...
Main Authors: | Xin Yin, Bei Tang, Jing-Huan Li, Yan Wang, Lan Zhang, Xiao-Ying Xie, Bo-Heng Zhang, Shuang-Jian Qiu, Wei-Zhong Wu, Zheng-Gang Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-017-0637-7 |
Similar Items
-
Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma
by: Marta Anna Kowalik, et al.
Published: (2017-05-01) -
The Role of the Pentose Phosphate Pathway in Diabetes and Cancer
by: Tongxin Ge, et al.
Published: (2020-06-01) -
Rôle fonctionnel des pentoses phosphates et glutamine dans le métabolisme des cellules cancéreuses
by: Polat, Ibrahim Halil
Published: (2016) -
The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
by: Isabella Giacomini, et al.
Published: (2020-01-01) -
Pentose-phosphate pathway disruption in the pathogenesis of Parkinson’s disease
by: Dunn Laura, et al.
Published: (2014-09-01)